ArticleJournal of clinical medicine research2014

Teneligliptin as an initial therapy for newly diagnosed, drug naive subjects with type 2 diabetes.

Eiji Kutoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.